Smoking Rates Drop 20% in Cambodia, New Study Shows

Feb.27.2023
Smoking Rates Drop 20% in Cambodia, New Study Shows
Smoking rates in Cambodia fell by one fifth between 2014-2021, with attitudes towards tobacco also changing.

New research findings reveal that the smoking rate in Cambodia decreased by one-fifth between 2014 and 2021.


Results from the 2021 National Adult Tobacco Survey in Cambodia indicate a decrease in overall smoking prevalence from 16.6% in 2014 to 13.04% in 2021. Male smoking prevalence experienced a decline of 6.93% from 32.3% in 2014 to 25.37% in 2021, while female smoking prevalence decreased from 2.4% in 2014 to 2.05% in 2021.


The attitude of Cambodians is also changing, as evidenced by a survey that found 95% of respondents support a hike in cigarette taxes and 95.75% support an increase in tobacco product prices.


The number of people exposed to tobacco has seen a significant decline from 2014 to 2021. The percentage of individuals exposed to tobacco smoke in their homes has reduced from 66% in 2014 to 27% in 2021. Similarly, the number of individuals exposed to tobacco smoke in their workplace has seen a 50% decrease, from 48% in 2014 to 24% in 2021.


However, concerning is the fact that despite the presence of anti-smoking laws, the exposure to tobacco smoke in public transportation has increased from 33% in 2014 to 62% in 2021.


Every year in Cambodia, over 16,000 people die from smoking, with one-third of those being the poorest individuals. If a smoking ban had been implemented earlier, every one of these preventable deaths could have been avoided. However, the tobacco industry remains active and deceitful in expanding its market, leading to an epidemic of tobacco-related illnesses.


Tobacco not only causes disease and death, but also has an impact on the economy: globally, the tobacco industry causes a loss of over $1.4 trillion USD (about 9.7 trillion RMB) each year. In Cambodia, the economic cost is over $227 million USD (about 1.58 billion RMB) per year due to healthcare expenses and lost productivity alone. Overall, Cambodia suffers an economic loss of $27 billion Cambodian riel (about 4.622 billion RMB) each year due to tobacco, equivalent to 3% of its gross domestic product.


References:


The prevalence of smoking has decreased in Cambodia.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

JT launches limited-edition Ploom AURA front panels; two go on sale, three offered via prize draw
JT launches limited-edition Ploom AURA front panels; two go on sale, three offered via prize draw
Japan Tobacco (JT) has rolled out an Ichiro Yamaguchi collaboration under its Ploom AURA “SENSATIONAL” campaign, using a combined marketing push—limited sales, a prize draw, video content distribution and in-store displays—to release five front panels and two branded accessories. Two panels will go on sale from Jan. 27, while the remaining panels and accessories will be distributed through a draw running from Jan. 19 to Feb. 28.
Jan.19 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Indonesian vape retailers’ association tells members to halt sales to under-21 customers
Indonesian vape retailers’ association tells members to halt sales to under-21 customers
The Indonesian Vape Retailers Association (Arvindo) has instructed all member stores to stop selling electronic cigarettes to customers under 21. Arvindo said it issued an official circular requiring vape shops to display 21+ signage and to ask customers for valid identification.
Feb.26
Rosstandart: packaging and design requirements for vapes to be tightened in early 2026
Rosstandart: packaging and design requirements for vapes to be tightened in early 2026
Rosstandart head Anton Shalaev told TASS that Russia will tighten requirements for the packaging and design of vapes and other electronic nicotine delivery systems in early 2026.
Jan.12 by 2FIRSTS.ai
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
British American Tobacco said 2026 will mark a return to its mid-term growth algorithm, but CEO Tadeu Marroco stressed that deliverywill depend heavily on enforcement against illicit vapour products in the United States. Speaking at the FY2025 results call, he positioned Modern Oral as the company’s primary structural growth engine, reframed accelerating cigarette declines through “poly-usage,” and reinforced capital discipline with an expanded share buyback plan.
Feb.12